From genome to "venome": molecular origin and evolution of the snake venom proteome inferred from phylogenetic analysis of toxin sequences and related body proteins.
This study analyzed the origin and evolution of snake venom proteome by means of phylogenetic analysis of the amino acid sequences of the toxins and related nonvenom proteins. The snake toxins were shown to have arisen from recruitment events of genes from within the following protein families: acetylcholinesterase, ADAM (disintegrin/metalloproteinase), AVIT, complement C3, crotasin/beta defensin, cystatin, endothelin, factor V, factor X, kallikrein, kunitz-type proteinase inhibitor, LYNX/SLUR, L-amino oxidase, lectin, natriuretic peptide, betanerve growth factor, phospholipase A(2), SPla/Ryanodine, vascular endothelial growth factor, and whey acidic protein/secretory leukoproteinase inhibitor. Toxin recruitment events were found to have occurred at least 24 times in the evolution of snake venom. Two of these toxin derivations (CRISP and kallikrein toxins) appear to have been actually the result of modifications of existing salivary proteins rather than gene recruitment events. One snake toxin type, the waglerin peptides from Tropidolaemus wagleri (Wagler's Viper), did not have a match with known proteins and may be derived from a uniquely reptilian peptide. All of the snake toxin types still possess the bioactivity of the ancestral proteins in at least some of the toxin isoforms. However, this study revealed that the toxin types, where the ancestral protein was extensively cysteine cross-linked, were the ones that flourished into functionally diverse, novel toxin multigene families.
Fry
Bryan G
BG
Australian Venom Research Unit, Level 8, School of Medicine, University of Melbourne, Parkville, Victoria 3010 Australia. bgf@unimelb.edu.au
D000818:Animals; D019143:Evolution, Molecular; D010802:Phylogeny; D020543:Proteome; D012910:Snake Venoms / Q000737:chemistry / Q000145:classification / Q000235:genetics*; D012911:Snakes / Q000235:genetics* / Q000378:metabolism; D014018:Tissue Distribution
D020543:Proteome; D012910:Snake Venoms
Toxicon. 2000 Mar;38(3):429-42
10669030
J Biol Chem. 1993 Aug 5;268(22):16458-64
8393864
Neuron. 2002 Mar 14;33(6):893-903
11906696
Eur J Biochem. 2002 Jun;269(11):2708-15
12047379
C R Biol. 2002 Sep;325(9):987-95
12481691
Bioinformatics. 2003 Aug 12;19(12):1572-4
12912839
J Biol Chem. 1993 Oct 15;268(29):21975-83
8408054
Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):878-82
8302860
J Membr Biol. 1994 Apr;139(1):49-55
8071987
Mol Phylogenet Evol. 1995 Mar;4(1):93-102
7620640
Biophys J. 1995 Jun;68(6):2280-8
7647234
J Biol Chem. 1995 Oct 20;270(42):25121-6
7559645
Exp Brain Res. 1996 Jun;110(1):15-20
8817251
Nucleic Acids Res. 1997 Dec 15;25(24):4876-82
9396791
Toxicon. 1998 Jun;36(6):847-57
9663691
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1998 Jul;120(1):99-110
9827022
Neuron. 1999 May;23(1):105-14
10402197
Eur J Pharmacol. 1999 Jun 18;374(2):189-96
10422759
Rapid Commun Mass Spectrom. 2003;17(18):2047-62
12955733
J Mol Evol. 2003 Jul;57(1):110-29
12962311
Hum Mol Genet. 2003 Nov 15;12(22):3017-24
14506129
J Mol Evol. 2003 Oct;57(4):446-52
14708577
Toxicon. 2003 Dec;42(7):747-52
14757205
Mol Biol Evol. 2004 May;21(5):870-83
15014162
Toxicon. 1987;25(1):65-106
3564066
Med Res Rev. 1990 Jan-Mar;10(1):115-42
2136927
Toxicon. 1990;28(3):299-309
1693019
Pharmacol Toxicol. 1992 Jun;70(6 Pt 1):459-62
1359525
J Biol Chem. 1993 Feb 15;268(5):3052-5
8428983
Bioinformatics. 2001 Aug;17(8):754-5
11524383